127 related articles for article (PubMed ID: 20032411)
1. Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis.
Sassa S; Okabe H; Nemoto N; Kikuchi H; Kudo H; Sakamoto S
Anticancer Res; 2009 Nov; 29(11):4615-9. PubMed ID: 20032411
[TBL] [Abstract][Full Text] [Related]
2. The more an ulcerative colitis is repeated, the more the risk of colorectal carcinogenesis is increased in mice.
Mitamura T; Sakamoto S; Sassa S; Suzuiki S; Kudo H; Okayasu I
Anticancer Res; 2002; 22(6C):3955-61. PubMed ID: 12553018
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive effect of a vitamin D(3) analog, alfacalcidol, on colorectal carcinogenesis in mice with ulcerative colitis.
Kikuchi H; Murakami S; Suzuki S; Kudo H; Sassa S; Sakamoto S
Anticancer Drugs; 2007 Nov; 18(10):1183-7. PubMed ID: 17893519
[TBL] [Abstract][Full Text] [Related]
4. Preventive effect of fluvastatin on ulcerative colitis-associated carcinogenesis in mice.
Suzuki S; Tajima T; Sassa S; Kudo H; Okayasu I; Sakamoto S
Anticancer Res; 2006; 26(6B):4223-8. PubMed ID: 17201137
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharides extracted from human tubercle bacilli (specific substance of Maruyama) reduces carcinogenesis in murine ulcerative colitis.
Sakamoto S; Okayasu I; Iida K; Fujita K; Yarimizu T; Nagasawa H
Anticancer Res; 2000; 20(6B):4295-9. PubMed ID: 11205261
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of sulphasalazine on colorectal carcinogenesis in mice with ulcerative colitis.
Suzuki S; Sakamoto S; Mitamura T; Sassa S; Kudo H; Yamashita Y
In Vivo; 2000; 14(3):463-6. PubMed ID: 10904883
[TBL] [Abstract][Full Text] [Related]
7. Effects of lentinan on colorectal carcinogenesis in mice with ulcerative colitis.
Mitamura T; Sakamoto S; Suzuki S; Yoshimura S; Maemura M; Kudo H
Oncol Rep; 2000; 7(3):599-601. PubMed ID: 10767375
[TBL] [Abstract][Full Text] [Related]
8. Increased proliferation of middle to distal colonic cells during colorectal carcinogenesis in experimental murine ulcerative colitis.
Inoue T; Murano M; Kuramoto T; Ishida K; Kawakami K; Abe Y; Morita E; Murano N; Toshina K; Nishikawa T; Maemura K; Shimamoto C; Hirata I; Katsu K; Higuchi K
Oncol Rep; 2007 Dec; 18(6):1457-62. PubMed ID: 17982630
[TBL] [Abstract][Full Text] [Related]
9. Promotion of colorectal neoplasia in experimental murine ulcerative colitis.
Okayasu I; Ohkusa T; Kajiura K; Kanno J; Sakamoto S
Gut; 1996 Jul; 39(1):87-92. PubMed ID: 8881816
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of nimesulide on colorectal carcinogenesis in experimental murine ulcerative colitis.
Inoue T; Murano M; Abe Y; Morita E; Murano N; Yasumoto S; Toshina K; Nishikawa T; Maemura K; Hirata I; Katsu K
J Gastroenterol Hepatol; 2007 Sep; 22(9):1474-81. PubMed ID: 17716351
[TBL] [Abstract][Full Text] [Related]
11. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
Ikeda I; Tomimoto A; Wada K; Fujisawa T; Fujita K; Yonemitsu K; Nozaki Y; Endo H; Takahashi H; Yoneda M; Inamori M; Kubota K; Saito S; Nagashima Y; Nakagama H; Nakajima A
Clin Cancer Res; 2007 Nov; 13(21):6527-31. PubMed ID: 17975166
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of an antiulcer agent, ecabet sodium on colorectal carcinogenesis in rodents.
Yarimizu T; Mitamura T; Suzuki S; Sakamoto S
Oncol Rep; 1998; 5(5):1103-7. PubMed ID: 9683817
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds.
Liao J; Seril DN; Yang AL; Lu GG; Yang GY
Carcinogenesis; 2007 Feb; 28(2):446-54. PubMed ID: 16973672
[TBL] [Abstract][Full Text] [Related]
14. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions.
Clapper ML; Cooper HS; Chang WC
Acta Pharmacol Sin; 2007 Sep; 28(9):1450-9. PubMed ID: 17723178
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice.
Carrier J; Medline A; Sohn KJ; Choi M; Martin R; Hwang SW; Kim YI
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1262-7. PubMed ID: 14652292
[TBL] [Abstract][Full Text] [Related]
16. Development of colonic neoplasms and expressions of p53 and p21 proteins in experimental colitis of mice induced by dextran sulfate sodium.
Takesue F; Korenaga D; Yao T; Kabashima A; Sugimachi K
J Exp Clin Cancer Res; 2001 Sep; 20(3):413-8. PubMed ID: 11718223
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice.
Kohno H; Suzuki R; Yasui Y; Miyamoto S; Wakabayashi K; Tanaka T
Clin Cancer Res; 2007 Apr; 13(8):2519-25. PubMed ID: 17438113
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice.
Liu ES; Ye YN; Shin VY; Yuen ST; Leung SY; Wong BC; Cho CH
Carcinogenesis; 2003 Aug; 24(8):1407-13. PubMed ID: 12807736
[TBL] [Abstract][Full Text] [Related]
19. Dextran sulfate sodium-induced ulcerative colitis leads to increased hematopoiesis and induces both local as well as systemic genotoxicity in mice.
Trivedi PP; Jena GB
Mutat Res; 2012 May; 744(2):172-83. PubMed ID: 22414559
[TBL] [Abstract][Full Text] [Related]
20. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model.
Okayasu I; Yamada M; Mikami T; Yoshida T; Kanno J; Ohkusa T
J Gastroenterol Hepatol; 2002 Oct; 17(10):1078-83. PubMed ID: 12201867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
